Microcap Ledger BioCardia, Inc. $BCDA
Facts as of . Built from SEC filings and our own data. Small caps move fast; check the latest filings.
Snapshot
- Exchange
- Nasdaq Capital Market
- Sector
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Sunnyvale, CA
- Fiscal year end
- December 31
- Shares outstanding
- 15,138,782 [10-Q 2026-08-12]
What the company doesAI summary of filing
BioCardia is a clinical-stage company developing autologous and allogeneic cell therapies for cardiovascular and pulmonary diseases. The company's lead program, CardiAMP, uses patients' own bone marrow cells delivered via a proprietary catheter system to treat ischemic heart failure and chronic myocardial ischemia; a Phase III trial for heart failure did not meet its primary endpoint but showed benefits in a biomarker-positive subgroup, and the company is pursuing FDA approval discussions. The company also develops CardiALLO, an off-the-shelf allogeneic mesenchymal stem cell therapy for heart failure in early-stage clinical trials, and PulmALLO for acute respiratory distress syndrome. Additionally, BioCardia licenses its Helix biotherapeutic delivery system to partners and manufactures and sells Morph vascular access catheters. [10-K 2026-03-24]
Financial health
| Period | Revenue | Net income | Operating cash flow | Cash | Filing |
|---|---|---|---|---|---|
| 6 months to Jun 2026 | — | −$3.87M | −$3.39M | $4.12M | [10-Q 2026-08-12] |
| FY ended Dec 2025 | $0.00 | −$8.23M | −$7.44M | $2.50M | [10-K 2026-03-24] |
| FY ended Dec 2024 | $58.0K | −$7.95M | −$7.89M | $2.37M | [10-K 2026-03-24] |
- Quarterly cash burn
- −$1.70M
- Cash runway Estimate
- ~7.3 months
Capital structure and dilution
| Date | Shares outstanding | Filing |
|---|---|---|
| 2024-11-05 | 4,584,285 | [10-Q 2024-11-13] |
| 2025-03-26 | 4,680,005 | [10-K 2025-03-26] |
| 2025-05-13 | 5,177,890 | [10-Q 2025-05-14] |
| 2025-08-08 | 5,801,224 | [10-Q/A 2025-10-29] |
| 2025-11-11 | 10,612,734 | [10-Q 2025-11-12] |
| 2026-03-24 | 10,940,372 | [10-K 2026-03-24] |
| 2026-05-13 | 11,374,724 | [10-Q 2026-05-15] |
| 2026-08-11 | 15,138,782 | [10-Q 2026-08-12] |
- Shelf registration
- S-1 filed 2025-09-16; declared effective 2025-09-18 [S-1 2025-09-16]
Listing status
Current status: 5 Form 8-K Item 3.01 filing(s) in the last 24 months, most recent 2026-08-21. Item 3.01 covers delisting notices, failures to meet a listing rule and listing transfers; read the filing for which one.
| Date | Event | Details | Deadline | Filing |
|---|---|---|---|---|
| 2026-08-21 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2026-08-21] |
| 2026-06-12 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2026-06-12] |
| 2026-04-15 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2026-04-15] |
| 2025-09-24 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2025-09-24] |
| 2025-04-04 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2025-04-04] |
Who owns it
| Date | Insider | Type | Shares | Price | Filing |
|---|---|---|---|---|---|
| 2026-09-29 | Altman Peter | buy | 1,000 | $1.03 | [4 2026-09-30] |
| 2026-09-23 | Altman Peter | buy | 1,900 | $1.05 | [4 2026-09-23] |
| 2026-09-03 | Altman Peter | buy | 800 | $1.09 | [4 2026-09-04] |
| 2026-08-17 | Altman Peter | buy | 5,400 | $0.93 | [4 2026-08-18] |
| 2026-08-13 | Altman Peter | buy | 1,900 | $0.92 | [4 2026-08-13] |
| 2026-07-29 | Altman Peter | buy | 5,000 | $0.78 | [4 2026-07-29] |
| 2026-07-17 | Altman Peter | buy | 500 | $0.83 | [4 2026-07-20] |
| 2026-07-15 | Altman Peter | buy | 1,500 | $0.86 | [4 2026-07-15] |
| 2026-07-14 | Altman Peter | buy | 2,800 | $0.88 | [4 2026-07-15] |
Catalysts and calendar
| Date | Type | Title |
|---|---|---|
| 2026-10-07 | 8-K | Other events |
| 2026-10-01 | 8-K | Other events |
| 2026-09-23 | 8-K | Other events |
| 2026-09-21 | 8-K | Other events |
| 2026-09-10 | 8-K | Other events |
| 2026-08-24 | 8-K | Regulation FD disclosure |
| 2026-08-21 | 8-K | Listing notice or transfer |
| 2026-08-12 | 8-K | Results of operations |
| 2026-08-12 | 10-Q | Quarterly report |
| 2026-06-18 | 8-K | Regulation FD disclosure |
| 2026-06-12 | 8-K | Listing notice or transfer |
| 2026-06-08 | 8-K | Other events |
Alerts for $BCDA
Email me when BioCardia, Inc. files an offering, gets a deficiency notice, or moves sharply.
Facts as of . Small caps move fast; check the latest filings.